28.03.2011 • News

3i Kicks Off Azelis Chemicals Sale

British private equity firm 3i Group has kicked off the sale of Azelis, a Belgium headquartered chemicals distributor with €1 billion euros in sales, people familiar with the situation said.

London-listed 3i has hired Bank of America Merrill Lynch to sell the company, which it acquired in 2007 in a €315 million deal, two people said.

The firm hopes to run a tightly controlled auction process, focusing on potential trade buyers, one of those people said. 3i declined to comment.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.